Concepedia

A. K. Sinha

AK

Statistics

Publications

16

Citations

609

H-Index

13

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Center for Drug Evaluation and Research

United States Food and Drug Administration

Yale University

A. K. Sinha is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and breast oncology.

Publications per year

2010–2025

16

Publications

16

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Denise Casey, Suzanne Demko, A. K. Sinha et al. · Clinical Cancer Research · 2021 · 107 citations

Medicine, Neurology, Pediatrics +12

Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity

Sangeetha M. Reddy, Carlos H. Bárcenas, A. K. Sinha et al. · British Journal of Cancer · 2017 · 104 citations · Full text

Medicine, Biostatistics, Oncology +17

Five-year all-cause mortality rates across five categories of substantiated elder abuse occurring in the community

Jason Burnett, Shelly L. Jackson, A. K. Sinha et al. · Journal of Elder Abuse & Neglect · 2016 · 81 citations

Social Sciences, Community Health, Geriatric Medicine +15

Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors

Akshara Singareeka Raghavendra, A. K. Sinha, Janeiro J. Valle‐Goffin et al. · Clinical Breast Cancer · 2017 · 46 citations · Full text

Medicine, Endocrinology, Oncology +17

FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC

Luckson Mathieu, Erin Larkins, A. K. Sinha et al. · Clinical Cancer Research · 2023 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 16